Implementation of pharmacokinetic-guided dosing of prophylaxis in hemophilia patients.

Registry ID

EUCTR2018-003869-33

Source registry

EUCTR

Status

Ongoing

Phase

PHASE4

Sponsor

Erasmus University Medical Center

Start date

2018-12-20

Last update

2026-08-16

Conditions

• Hemophilia

Summary

1. Observed FVIII and FIX levels in comparison to predicted FVIII and FIX levels by population PK-modeling (predictive performance).

Locations

• , , Netherlands

Related clinical trials

• A Phase Ib Safety, Pharmacokinetics and Pharmacodynamics Study of TU7710 in Patients with Haemophilia A or B
• Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
• ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
• An open-label, parallel, Phase 3, two-arm study to investigate the efficacy and safety of fitusiran prophylaxis in male participants aged 1 to less than 12 years with hemophilia A or B with or without inhibitory antibodies to Factors VIII or IX
• Multimodal Telerehabilitation Versus Face-to-Face Care for Adults With Hemophilia and Chronic Pain
• A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B

View on source registry